Literature DB >> 27902889

The Complexities of Doctor-Patient-Family Communication in an Asian Oncology Setting: Concordance and Discordance Among Patient Preferences, Family Preferences, and Perceived and Actual Communication.

Geok Ling Lee1, Irene Teo2, Ravindran Kanesvaran3.   

Abstract

This article reports on a pilot study that examined the complexities of doctor-patient-family communication in an oncology setting in Singapore. Twenty consultation visits were audio-recorded and a postconsultation questionnaire was administered to patients and their accompanying person (AP) to examine their communication preferences. Patients and APs rated physician expertise and message content as highly important; supportive elements of the communication were rated as less important. Patients preferred information concerning their condition, while APs preferred information regarding treatment options. There was discordance between what was perceived by the patient/AP and actual delivery, and within patient-AP dyads. Our findings elucidate some of the complexities in communication preferences in an Asian oncology context that can inform clinical practice.

Entities:  

Mesh:

Year:  2016        PMID: 27902889     DOI: 10.1080/10410236.2016.1239303

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  2 in total

1.  The relationship between personality traits of cancer patients and their preferences when receiving bad news.

Authors:  Maryam Ehsani; Mansoureh Ashghali Farahani; Fatemeh Negari; Hadi Ranjbar; Behnam Shariati; Fatemeh Marandi
Journal:  Support Care Cancer       Date:  2021-10-31       Impact factor: 3.603

2.  Adapting ENABLE for patients with advanced cancer and their family caregivers in Singapore: a qualitative formative evaluation.

Authors:  Grace Meijuan Yang; J Nicholas Dionne-Odom; Yi Han Foo; Ariel Hui Mei Chung; Nur Haidah Ahmad Kamal; Laurence Tan; Chou Chuen Yu; Le Mai Khanh; Audrey Rui Xuan Koh; Irene Teo; Sungwon Yoon; Marie Bakitas
Journal:  BMC Palliat Care       Date:  2021-06-22       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.